Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

CareRay Digital Medical Technology Co., Ltd. (688607.SS)

Compare
17.86
0.00
(0.00%)
At close: April 3 at 3:00:01 PM GMT+8
Loading Chart for 688607.SS
  • Previous Close 17.86
  • Open 17.61
  • Bid 17.84 x --
  • Ask 17.86 x --
  • Day's Range 17.20 - 18.00
  • 52 Week Range 9.81 - 18.94
  • Volume 1,843,018
  • Avg. Volume 1,632,274
  • Market Cap (intraday) 1.574B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 66.15
  • EPS (TTM) 0.27
  • Earnings Date --
  • Forward Dividend & Yield 0.05 (0.30%)
  • Ex-Dividend Date Jun 17, 2024
  • 1y Target Est --

CareRay Digital Medical Technology Co., Ltd. engages in research and development, manufacturing, sales, and marketing of digital X-ray flat panel detectors in China. The company offers wireless high-speed dynamic boards, new CMOS sensors, and IGZO new flat panel detectors. Its products are used for clinical examinations, such as medical radiographs, breast examinations, fluoroscopy, and pet medical treatment, as well as treatment of radiotherapy and interventional surgery. The company was founded in 2007 and is headquartered in Suzhou, China.

www.careray.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688607.SS

View More

Performance Overview: 688607.SS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688607.SS
34.79%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

688607.SS
17.51%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

688607.SS
31.59%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

688607.SS
60.27%
SSE Composite Index (000001.SS)
20.91%

Compare To: 688607.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688607.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.57B

  • Enterprise Value

    1.16B

  • Trailing P/E

    66.15

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.97

  • Price/Book (mrq)

    1.84

  • Enterprise Value/Revenue

    4.02

  • Enterprise Value/EBITDA

    41.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.95%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    2.04%

  • Revenue (ttm)

    293.9M

  • Net Income Avi to Common (ttm)

    17.48M

  • Diluted EPS (ttm)

    0.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    435.84M

  • Total Debt/Equity (mrq)

    2.29%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 688607.SS

View More

Company Insights: 688607.SS

Research Reports: 688607.SS

View More

People Also Watch